ORIGINAL ARTICLE
Expression of C-terminal tensin-like in breast carcinoma and its correlation with known prognostic factors
 
More details
Hide details
1
Department of Pathology, King Edward Medical University Lahore, Pakistan
 
2
Department of Pathology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
 
 
Submission date: 2024-02-14
 
 
Final revision date: 2024-12-13
 
 
Acceptance date: 2025-02-02
 
 
Publication date: 2025-05-10
 
 
Corresponding author
Shahzada Khalid Sohail
Dr. Shahzada Khalid Sohail, FCPS, Assistant Professor of Pathology Department of Pathology College of Medicine University of Bisha, Bisha 61922, Saudi Arabia
 
 
Pol J Pathol 2025;76(1):10-15
 
KEYWORDS
TOPICS
ABSTRACT
C-terminal tensin-like (Cten) is a marker for poorly differentiated breast cancer. We evaluated the immunohistochemical expression of Cten in invasive breast carcinoma in our population and correlated it with known histopathologic prognostic variables.
Fifty-seven specimens of modified radical mastectomy diagnosed as invasive ductal carcinoma were collected. The histopathologic findings were noted independent of the result of Cten. According to the results of Cten immunohistochemistry, the tumors were categorized as negative/mild, moderate, or high expression and were statistically corelated with histologic findings.
In our study, 47 (82.5%) cases showed negative/mild expression, 2 (3.5%) cases showed moderate staining, and 8 (14%) cases showed strong expression of Cten.
Positive Cten was present in pT4 stage tumors. Similarly, grade III tumor showed moderate expression in 2 (3.5%) cases and strong staining in 8 (14%) cases. Posi-tive expression of Cten was observed in cases with lymphovascular invasion (LVI) and high axillary lymph nodal involvement (N3). All these poor prognostic factors were significantly associated with moderate to high expression of Cten.
We found that tumor size and extent, histologic grade, LVI, and lymph node status were significantly associated with Cten expression. C-terminal tensin-like can be used as marker of poor prognosis in breast carcinoma.
REFERENCES (15)
1.
Albasri A, Aleskandarany M, Benhasouna A, et al. CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis. Breast Cancer Res Treat 2011; 126: 47-54.
 
2.
Lu X, Zhou B, Cao M, Shao Q, Pan Y, Zhao T. CTEN inhibits tumor angiogenesis and growth by targeting VEGFA through down-regulation of β-catenin in breast cancer. Technol Cancer Res Treat 2021; 20: 15330338211045506.
 
3.
Samman A, Hanbazazh M, Samargandy S, Al-Maghrabi J. Expression of p16 protein in breast cancer. Pol J Pathol 2024; 75:19-24.
 
4.
Yalçın Ö, Kulduk G. Tumour budding in invasive breast carcinoma of no special type relationship with clinicopathological parameters. Pol J Pathol 2024; 75: 77-82.
 
5.
Hong SY, Shih YP, Li T, Carraway KL, Lo SH. CTEN prolongssignaling by EGFR through reducing its ligandinduced degradation. Cancer Res 2013; 73: 5266-5276.
 
6.
Lüönd F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer 2021; 125: 164-175.
 
7.
Lo SH. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer. Int J Biochem Cell Biol 2014; 5: 150-154.
 
8.
Alghamdi S, Alkwai S, Ilyas M. The role of C-terminal tensin like (Cten) gene in cancer metastasis. J Biochem Clin Genet 2018; 1: 2-9.
 
9.
Hong SY, Shih YP, Lo A, Lo SH. Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation. Mol Cell Res 2019; 1866: 450-458.
 
10.
Liao YC, Lo SH. Tensins – emerging insights into their do main functions, biological roles and disease relevance. J Cell Sci 2021; 134: jcs254029.
 
11.
Nizioł M, Pryczynicz A. The role of tensins in malignant neoplasms. Arch Med Sci 2023; 19: 1382-1397.
 
12.
Kawiak A. Molecular research and treatment of breast cancer. Int J Mol Sci 2022; 23: 9617.
 
13.
Katz M, Amit I, Citri A, et al. A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration. Nat Cell Biol 2007; 9: 961-969.
 
14.
Shehzad K, Alam S, Shams MU, Riaz S, Khan HA, Khan RU. Frequency and pathologic features of triple negative breast cancer at a tertiary care hospital in Pakistan. Ann Punjab Med College 2021; 15: 136-138.
 
15.
Sohail SK, Sarfraz R, Imran M, Kamran M, Qamar S. Estrogen and progesterone receptor expression in breast carcinoma and its association with clinicopathological variables among the Pakistani population. Cureus 2020; 12: e9751.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top